Authors: Capizzi, RL Oster, W

Citation: Rl. Capizzi et W. Oster, Chemoprotective and radioprotective effects of amifostine: An update of clinical trials, INT J HEMAT, 72(4), 2000, pp. 425-435

Authors: Brizel, DM Wasserman, TH Henke, M Strnad, V Rudat, V Monnier, A Eschwege, F Zhang, J Russell, L Oster, W Sauer, R

Citation: Dm. Brizel et al., Phase III randomized trial of amifostine as a radioprotector in head and neck cancer, J CL ONCOL, 18(19), 2000, pp. 3339-3345

Authors: Wasserman, T Mackowiak, JI Brizel, DM Oster, W Zhang, JL Peeples, PJ Sauer, R

Citation: T. Wasserman et al., Effect of amifostine on patient assessed clinical benefit in irradiated head and neck cancer, INT J RAD O, 48(4), 2000, pp. 1035-1039

Authors: Herrmann, F Bambach, T Bonifer, R Lindemann, A Riedel, D Oster, W Mertelsmann, R

Citation: F. Herrmann et al., The suppressive effects of recombinant human tumor necrosis factor-alpha on normal and malignant myelopoiesis: Synergism with interferon-gamma (retraction from the International Journal of Cell Cloning, vol 6, pg 241-261, 1988), STEM CELLS, 17(4), 1999, pp. 241-241

Authors: Planting, AST Catimel, G de Mulder, PHM de Graeff, A Hoppener, F Verweij, J Oster, W Vermorken, JB

Citation: Ast. Planting et al., Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer, ANN ONCOL, 10(6), 1999, pp. 693-700

Authors: Oster, W Brach, MA Gruss, HJ Mertelsmann, R Herrmann, F

Citation: W. Oster et al., Interleukin-1 beta (IL-1 beta) expression in human blood mononuclear phagocytes is differentially regulated by granulocyte-macrophage colony-stimulating factor (GM-CSF), M-CSF and IL-3 (Retraction of vol 79, pg 1260, 1992), BLOOD, 93(10), 1999, pp. 3573-3573